Somerset Indus Capital Partners, a healthcare-focused private equity firm which has backed companies such as Genworks, ...
Management targets JPY 65 billion-JPY 75 billion in capital expenditure per year over the medium term. We think its operating cash flow could support such a level of investments, but the dividend ...